BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 16941223)

  • 1. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
    Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.
    Elasfar A
    Ann Saudi Med; 2012; 32(5):469-72. PubMed ID: 22871614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip.
    Kaneko H; Neuss M; Schau T; Weissenborn J; Butter C
    Heart Vessels; 2016 Dec; 31(12):1988-1996. PubMed ID: 26968992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum biomarker profiles after percutaneous mitral valve repair with the MitraClip system.
    Yoon JN; Frangieh AH; Attinger-Toller A; Gruner C; Tanner FC; Taramasso M; Corti R; Lüscher TF; Ruschitzka F; Bettex D; Maisano F; Gaemperli O
    Cardiol J; 2016; 23(4):384-92. PubMed ID: 27296161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-pro-brain natriuretic peptide levels after valve replacement.
    Elasfar AA
    Asian Cardiovasc Thorac Ann; 2011 Dec; 19(6):399-402. PubMed ID: 22160408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Transcatheter Mitral Valve Repair With MitraClip on Left Ventricular and Atrial Hemodynamic Load and Myocardial Wall Stress.
    van Wijngaarden SE; Kamperidis V; Al-Amri I; van der Kley F; Schalij MJ; Ajmone Marsan N; Bax JJ; Delgado V
    J Card Fail; 2018 Mar; 24(3):137-145. PubMed ID: 29292112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.
    Rubino AS; Onorati F; Santarpino G; Pasceri E; Santarpia G; Cristodoro L; Serraino GF; Renzulli A
    Ann Thorac Surg; 2009 Sep; 88(3):719-25. PubMed ID: 19699885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time-course changes of NT-proBNP and tissue Doppler indices in patients undergoing mitral valve replacement.
    Prakaschandra DR; Esterhuizen T; Naidoo DP
    Cardiovasc J Afr; 2012 May; 23(4):200-5. PubMed ID: 22614663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
    Untersteller K; Girerd N; Duarte K; Rogacev KS; Seiler-Mussler S; Fliser D; Rossignol P; Heine GH
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1978-1988. PubMed ID: 27515593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation.
    Westhoff-Bleck M; Kornau F; Haghikia A; Horke A; Bertram H; Treptau J; Widder J; Bauersachs J; Brehm MU
    Can J Cardiol; 2016 Oct; 32(10):1247.e29-1247.e36. PubMed ID: 26927857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Primary Mitral Regurgitation and Preserved Systolic Function Undergoing Mitral Valve Surgery.
    Alashi A; Mentias A; Patel K; Gillinov AM; Sabik JF; Popović ZB; Mihaljevic T; Suri RM; Rodriguez LL; Svensson LG; Griffin BP; Desai MY
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27342145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
    Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
    Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure.
    Taléns-Visconti R; Rivera M; Climent V; Valero R; Martínez-Dolz L; Sancho-Tello MJ; Cortés R; Miro V; Sevilla B; Perez-Bosca JL; Bertomeu V; Salvador A; Jordan A; Marin F; Sogorb F
    Echocardiography; 2006 Apr; 23(4):295-302. PubMed ID: 16640706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Right Ventricular Dysfunction and Diabetes Mellitus in N-terminal pro-B-type Natriuretic Peptide Response of Patients With Severe Mitral Regurgitation and Heart Failure After MitraClip.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Int Heart J; 2017 Apr; 58(2):225-231. PubMed ID: 28216549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
    Nah EH; Kim SY; Cho S; Kim S; Cho HI
    BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.